Form 4 for OTLK Outlook Therapeutics, Inc.
Accepted 2026-06-03 18:03:16 ET · period of report 2026-06-02 · accession 0001649989-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 18:03 | 2026-06-02 | OTLK | Haddadin Yezan Munther | Dir | P - Purchase | $0.8326 | +29.0K | 66.2K | +78% | +$24.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-02 | P | A | 29,000 | $0.8326 | 66,167 | D | — | — |